Page 45 - Device Designation News Today : Breaking News, Liv

Rheon Medical is revolutionizing surgical treatment of glaucoma

Published: August 18, 2021

EPFL spin-off Rheon Medical has developed the world's first adjustable glaucoma drainage system, which has already been used successfully in over 250...

Source: miragenews.com

Breakthrough Israeli stroke therapy technology startup BrainQ announces $40 million round

Published: August 16, 2021

The round was led by Hanaco Ventures, alongside Dexcel Pharma, and Peregrine Ventures, bringing the total funding to over $50 million. Funds to be used to support company’s pivotal trials for stroke survivors in U.S. hospitals

Source: calcalistech.com

Israeli stroke therapy co BrainQ raises $40m

Published: August 16, 2021

The Jerusalem-based company's investigational cloud-based technology aims to reduce disability and promote rehabilitation neurorecovery for stroke victims.

Source: globes.co.il

Alpha Tau Gets FDA Breakthrough Device Designation For Cancer Therapy

Published: June 13, 2021

Founded in 2016, Alpha Tau developed a breakthrough cancer treatment called Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy).

Source: nocamels.com

AI Cancer Diagnostics Firm Ibex Granted FDA Breakthrough Device Designation

Published: June 9, 2021

AI Cancer Diagnostics Firm Ibex Granted FDA Breakthrough Device Designation News BriefsTech & Innovation Pathologists review a cancer alert on Ibex’s AI solution. Courtesy Israeli AI-powered cancer diagnostics company Ibex Medical Analytics announced on Wednesday that it was granted Breakthrough Device Designation by the US Food and Drug Administration (FDA) for its Galen platform that helps pathologists detect and grade cancer in biopsies. Ibex’s Galen Prostate and Galen Breast are the first AI-powered cancer diagnostics solutions in routine clinical use in pathology and are deployed in...